Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections [Erratum]
Nicolau DP, Silberg BN. Infect Drug Resist. 2017;10:227–230.Page 227, affiliations list, the text “Department of Surgery, Sonoma West Medical Center, Sebastopol, CT, USA” should read “Department of Surgery, Sonoma West Medical Center, Sebastopol, CA, USA&r...
Main Authors: | Nicolau DP, Silberg BN |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-08-01
|
Series: | Infection and Drug Resistance |
Online Access: | https://www.dovepress.com/erratum-cefazolin-potency-against-methicillin-resistant-staphylo-peer-reviewed-article-IDR |
Similar Items
-
Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections
by: Nicolau DP, et al.
Published: (2017-07-01) -
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
by: Benjamin H. Gern, et al.
Published: (2018-02-01) -
Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
by: Marguerite L. Monogue, et al.
Published: (2018-09-01) -
Methicillin-resistant Staphylococcus aureus Skin Infections
by: Jui-Shan Ma, et al.
Published: (2005-10-01) -
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible <it>Staphylococcus aureus </it>bacteremia
by: McGregor Jessina C, et al.
Published: (2011-10-01)